Michael Back Dalgaard

Michael Back Dalgaard is an experienced professional in immunology and parasitology, currently serving as Associate Director and Team Lead for CMC New Product Introduction at Genmab since January 2018. Prior to this role, Michael held various positions at Novo Nordisk from March 2013 to January 2018, including Senior Scientist focused on immunogenicity assessment and cell and antibody analysis. Academic experience includes a postdoctoral position at the Centre for Medical Parasitology, University of Copenhagen, where Michael developed molecular techniques for producing human monoclonal antibodies. Michael's early career involved research roles in malaria and fish diseases, culminating in a Ph.D. in Immunology and Parasitology from the University of Copenhagen, earned in 2010.